ARTICLE | Clinical News
Zadaxin: Phase III data
May 29, 2006 7:00 AM UTC
Data from a U.S. Phase III trial in about 500 HCV patients, with early liver cirrhosis and who failed prior therapy, showed that Zadaxin plus pegylated interferon alpha missed the primary endpoint. Sp...